PSYENCE BIOMEDICAL LTD.

Analysis for Ticker: PBM

Psyence Biomedical Ltd operates a clinical-stage biotechnology business focused on making therapeutics from natural psilocybin and ibogaine for patients needing palliative care. The financial reality is a company that spent 41,4$ million just to join the stock market but has never sold a single pill. Imagine a bakery that spends all its money on a shiny storefront but has no flour or customers. The current math is a disaster because every dollar an investor puts in is being siphoned off by the bosses to buy private companies they already own.